Tetrahydrobiopterin | CAS#17528-72-2 | co-factor

MedKoo Cat#: 584615 | Name: Tetrahydrobiopterin

Description:

WARNING: This product is for research use only, not for human or veterinary use.

Tetrahydrobiopterin is a co-factor required for catalytic activity of nitric oxide synthases.

Chemical Structure

Tetrahydrobiopterin

CAS#17528-72-2

Theoretical Analysis

MedKoo Cat#: 584615

Name: Tetrahydrobiopterin

CAS#: 17528-72-2

Chemical Formula: C9H15N5O3

Exact Mass: 241.1175

Molecular Weight: 241.25

Elemental Analysis: C, 44.81; H, 6.27; N, 29.03; O, 19.90

Price and Availability

This product is currently not in stock but may be available through custom synthesis. To ensure cost efficiency, the minimum order quantity is 1 gram. The estimated lead time is 2 to 4 months, with pricing dependent on the complexity of the synthesis (typically high for intricate chemistries). Quotes for quantities below 1 gram will not be provided. To request a quote, please click the button below. Note: If this product becomes available in stock in the future, pricing will be listed accordingly.

Bulk Inquiry

Related CAS #

No Data

Synonym

Tetrahydrobiopterin

IUPAC/Chemical Name

4(1H)-Pteridinone, 5,6,7,8-tetrahydro-2-amino-6-(1,2-dihydroxypropyl)-

InChi Key

FNKQXYHWGSIFBK-UHFFFAOYSA-N

InChi Code

InChI=1S/C9H15N5O3/c1-3(15)6(16)4-2-11-7-5(12-4)8(17)14-9(10)13-7/h3-4,6,12,15-16H,2H2,1H3,(H4,10,11,13,14,17)

SMILES Code

O=C1N=C(N)NC2=C1NC(C(O)C(O)C)CN2

Appearance

Solid powder

Purity

>98% (or refer to the Certificate of Analysis)

Shipping Condition

Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition

Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility

Soluble in DMSO

Shelf Life

>3 years if stored properly

Drug Formulation

This drug may be formulated in DMSO

Stock Solution Storage

0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code

2934.99.03.00

More Info

Instruction

View handling instruction

Preparing Stock Solutions

The following data is based on the product molecular weight 241.25 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Concentration / Solvent Volume / Mass	1 mg	5 mg	10 mg
1 mM	1.15 mL	5.76 mL	11.51 mL
5 mM	0.23 mL	1.15 mL	2.3 mL
10 mM	0.12 mL	0.58 mL	1.15 mL
50 mM	0.02 mL	0.12 mL	0.23 mL

1: Tani Y, Ohno T. Analysis of 6R- and 6S-tetrahydrobiopterin and other pterins by reversed-phase ion-pair liquid-chromatography with fluorimetric detection by post-column sodium nitrite oxidation. J Chromatogr. 1993 Aug 11;617(2):249-55. PubMed PMID: 8408390. 2: Tejero J, Stuehr D. Tetrahydrobiopterin in nitric oxide synthase. IUBMB Life. 2013 Apr;65(4):358-65. doi: 10.1002/iub.1136. Epub 2013 Feb 26. Review. PubMed PMID: 23441062. 3: Starr A, Hussein D, Nandi M. The regulation of vascular tetrahydrobiopterin bioavailability. Vascul Pharmacol. 2013 Mar;58(3):219-30. Review. PubMed PMID: 23634439. 4: Heintz C, Cotton RG, Blau N. Tetrahydrobiopterin, its mode of action on phenylalanine hydroxylase, and importance of genotypes for pharmacological therapy of phenylketonuria. Hum Mutat. 2013 Jul;34(7):927-36. doi: 10.1002/humu.22320. Epub 2013 May 1. Review. PubMed PMID: 23559577. 5: Tang LL, Zheng JS. Effects of tetrahydrobiopterin on cerebral infarction after transient focal ischemia in rats. Neurol Res. 2011 Dec;33(10):1064-7. doi: 10.1179/016164110X12700393823651. Epub 2010 May 19. PubMed PMID: 20487600. 6: Werner ER, Blau N, Thöny B. Tetrahydrobiopterin: biochemistry and pathophysiology. Biochem J. 2011 Sep 15;438(3):397-414. doi: 10.1042/BJ20110293. Review. PubMed PMID: 21867484. 7: De Maria R, Campolo J, Frontali M, Taroni F, Federico A, Inzitari D, Tavani A, Romano S, Puca E, Orzi F, Francia A, Mariotti C, Tomasello C, Dotti MT, Stromillo ML, Pantoni L, Pescini F, Valenti R, Pelucchi C, Parolini M, Parodi O; CADASIL Study Investigators. Effects of sapropterin on endothelium-dependent vasodilation in patients with CADASIL: a randomized controlled trial. Stroke. 2014 Oct;45(10):2959-66. doi: 10.1161/STROKEAHA.114.005937. Epub 2014 Sep 2. PubMed PMID: 25184356. 8: Maglione M, Cardini B, Oberhuber R, Watschinger K, Jenny M, Gostner J, Hermann M, Obrist P, Margreiter R, Pratschke J, Brandacher G, Werner ER. Prevention of lethal murine pancreas ischemia reperfusion injury is specific for tetrahydrobiopterin. Transpl Int. 2012 Oct;25(10):1084-95. doi: 10.1111/j.1432-2277.2012.01530.x. Epub 2012 Jul 17. PubMed PMID: 22805419; PubMed Central PMCID: PMC3499685. 9: Rohr F, Wessel A, Brown M, Charette K, Levy HL. Adherence to tetrahydrobiopterin therapy in patients with phenylketonuria. Mol Genet Metab. 2015 Jan;114(1):25-8. doi: 10.1016/j.ymgme.2014.10.013. Epub 2014 Oct 31. PubMed PMID: 25467057. 10: Bendall JK, Douglas G, McNeill E, Channon KM, Crabtree MJ. Tetrahydrobiopterin in cardiovascular health and disease. Antioxid Redox Signal. 2014 Jun 20;20(18):3040-77. doi: 10.1089/ars.2013.5566. Epub 2014 Mar 14. Review. PubMed PMID: 24294830; PubMed Central PMCID: PMC4038990. 11: Chen L, Ding ML, Wu F, He W, Li J, Zhang XY, Xie WL, Duan SZ, Xia WH, Tao J. Impaired Endothelial Repair Capacity of Early Endothelial Progenitor Cells in Hypertensive Patients With Primary Hyperaldosteronemia: Role of 5,6,7,8-Tetrahydrobiopterin Oxidation and Endothelial Nitric Oxide Synthase Uncoupling. Hypertension. 2016 Feb;67(2):430-9. doi: 10.1161/HYPERTENSIONAHA.115.06597. Epub 2015 Nov 30. PubMed PMID: 26628675. 12: Cerone R, Andria G, Giovannini M, Leuzzi V, Riva E, Burlina A. Testing for tetrahydrobiopterin responsiveness in patients with hyperphenylalaninemia due to phenylalanine hydroxylase deficiency. Adv Ther. 2013 Mar;30(3):212-28. doi: 10.1007/s12325-013-0011-x. Epub 2013 Feb 20. Review. PubMed PMID: 23436109. 13: Koshimura K, Ohue T, Watanabe Y, Miwa S. 6R-L-erythro-5,6,7,8-tetrahydrobiopterin: a regulator of neurotransmitter release. Adv Exp Med Biol. 1993;338:313-9. PubMed PMID: 8304128. 14: Chen DD, Chen LY, Xie JB, Shu C, Yang T, Zhou S, Yuan H, Chen AF. Tetrahydrobiopterin regulation of eNOS redox function. Curr Pharm Des. 2014;20(22):3554-62. Review. PubMed PMID: 24180387. 15: Gassió R, Vilaseca MA, Lambruschini N, Boix C, Fusté ME, Campistol J. Cognitive functions in patients with phenylketonuria in long-term treatment with tetrahydrobiopterin. Mol Genet Metab. 2010;99 Suppl 1:S75-8. doi: 10.1016/j.ymgme.2009.10.187. PubMed PMID: 20123475. 16: Vásquez-Vivar J. Tetrahydrobiopterin, superoxide, and vascular dysfunction. Free Radic Biol Med. 2009 Oct 15;47(8):1108-19. doi: 10.1016/j.freeradbiomed.2009.07.024. Epub 2009 Jul 21. Review. PubMed PMID: 19628033; PubMed Central PMCID: PMC2852262. 17: Dikalova A, Aschner JL, Kaplowitz MR, Summar M, Fike CD. Tetrahydrobiopterin oral therapy recouples eNOS and ameliorates chronic hypoxia-induced pulmonary hypertension in newborn pigs. Am J Physiol Lung Cell Mol Physiol. 2016 Oct 1;311(4):L743-L753. doi: 10.1152/ajplung.00238.2016. Epub 2016 Aug 19. PubMed PMID: 27542807; PubMed Central PMCID: PMC5142125. 18: Tani Y, Ishihara T, Kanai T, Ohno T, Onoe H, Watanabe Y, Andersson J, Lilija A, Westerberg G, Hartvig P, et al. Positron emission tomography (PET) study: the effects of 6R-L-erythro-5,6,7,8-tetrahydrobiopterin (R-THBP, SUN 0588) on the central dopamine D1, D2 and D3 receptors in rhesus monkey. Adv Exp Med Biol. 1993;338:327-30. PubMed PMID: 8304130. 19: Frye RE, DeLatorre R, Taylor HB, Slattery J, Melnyk S, Chowdhury N, James SJ. Metabolic effects of sapropterin treatment in autism spectrum disorder: a preliminary study. Transl Psychiatry. 2013 Mar 5;3:e237. doi: 10.1038/tp.2013.14. PubMed PMID: 23462988; PubMed Central PMCID: PMC3625913. 20: Wang ZF, Chen Jin-Wen, Tie L, Li XJ. [Tetrahydrobiopterin Synthesis and Biological Function]. Sheng Li Ke Xue Jin Zhan. 2015 Aug;46(4):259-64. Review. Chinese. PubMed PMID: 26669076.